Third Strike For Gepirone ER: Fabre-Kramer/GSK Antidepressant “Not Approvable” Again
Antidepressant received two FDA “not approvable” letters when it was licensed to Organon.
Antidepressant received two FDA “not approvable” letters when it was licensed to Organon.